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Recurrent infection with herpes simplex virus is a
common disease. Recently, alternative therapies have
been introduced. Among those, low-intensity laser
therapy mainly used for the acceleration of wound
healing and in pain therapy has previously been shown
to be of benefit in herpes zoster infections. In this
study we evaluated the influence of low-intensity laser
therapy (wavelength 690 nm, intensity: 80 mW per
cm2, dose: 48 J per cm2) in 50 patients with recurrent
perioral herpes simplex infection (at least once per
month for more than 6 mo) in a randomized, double-
blind placebo-controlled trial design. Patients in the
laser group received daily irradiations for 2 wk, whereas
patients in the placebo group were sham-irradiated.
After completion of the laser/sham treatment, patients
were asked to return to the Department of Dermato-
Perioral infection with herpes simplex virus (HSV) is acommon disease with an estimated 16%–45% of thepopulation having been infected, mainly in early child-hood (Vestey and Norval, 1992). There is no seasonalvariation in the incidence of infection. After infection
of nerve endings, viruses are transported to the nuclei of the sensory
ganglia where they multiply (Whitley and Kimberlin, 1998).
Between 28 and 60% of individuals with latent herpes simplex
suffer from recrudescence with a frequency of 2–20 per y (Norval
and el Ghorr, 1996; Whitley and Kimberlin, 1998). Reactivations
can be triggered by physical or emotional stress, fever, exposure to
ultraviolet light, and immune suppression. The onset of recurrence
is preceded by pain, burning, or itching which generally persists
for about 6 h and is followed by the appearance of vesicles. Lesions
progress to pustules or ulcers and usually heal within 8–10 d.
Immune responses to herpes simplex infection involve Langerhans
cells, lymphocyte-mediated delayed-type hypersensitivity and
cytotoxicity, macrophages, and natural killer cells (Whitley and
Kimberlin, 1998). There is evidence that a temporary depression
in immunologic responses might occur shortly before or during
recrudescence (Vestey and Norval, 1992). Development of drug-
resistant HSV strains is of increasing significance, especially in
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logy, University of Vienna Medical School at the time
of recurrence. All except two patients completed the
study and were monitored for 52 wk. The median
recurrence-free interval in the laser-treated group was
37.5 wk (range: 2–52 wk) and in the placebo group
3 wk (range: 1–20 wk). This difference was found to
be statistically significant (p < 0.0001; Wilcoxon’s Rank
Sum Test). In conclusion, we demonstrated that a
total of 10 irradiations with low-intensity laser therapy
significantly lowers the incidence of local recurrence
of herpes simplex infection. Since this athermic photo-
therapeutic modality represents a safe, noninvasive
treatment, it might be considered as an alternative to
established therapeutic regimens in this indication. Key
words: biostimulation/immunology/low level laser/virus. J
Invest Dermatol 113:221–223, 1999
immunocompromised patients such as organ transplant recipients
and AIDS patients (Whitley and Kimberlin, 1998).
Low-intensity laser therapy represents an athermic phototherapy
utilizing light sources emitting low energies (in the milliwatt range)
of usually red or near infrared monochromatic light and is mainly
used for the acceleration of wound healing (Al-Watban and Zhang,
1996; Schindl et al, 1997a, b; Halevy et al, 1997; Yu et al,
1997a) and in pain therapy (Walker, 1983; Emmanoulidis and
Diamantopoulos, 1986; Moore et al, 1988). Additionally, it has
been shown that this type of phototherapy might have an effect
on several immunologic reactions (Ohta et al, 1987; Yu et al, 1997b;
Schindl et al, 1997c). These findings have influenced a number of
uncontrolled clinical studies about the effect of low-intensity laser
therapy on herpes simplex infection (Haichenberger-Wildner and
Michels, 1981; Landthaler et al, 1983).
Our study evaluates the efficacy of low-intensity laser therapy in
the treatment of recurrent herpes simplex infection in a randomized,
double-blind placebo-controlled trial design.
MATERIALS AND METHODS
Patients Fifty consecutive patients who presented or were referred to
the Department of Dermatology, University of Vienna Medical School
due to recurrent herpes simplex infections of the perioral region were
included in this study. All patients had had at least one course of treatment
with orally applied acyclovir (800 mg per d) for 4 wk, which had been
completed at least 3 mo before enrolment. Recurrent herpes simplex
infection was defined as at least one herpes attack per month for more
than 6 mo independent of any known triggering mechanism such as fever,
sun exposure, or menstruation. Patients were randomized into a laser group
and a placebo group (n 5 25 for both groups) after signing informed
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Table I. Demographic characteristics of study population
with recurrent perioral herpes simplex infection (at least
one recurrence within the last 6 mo)
Laser group (n 5 24) Placebo group (n 5 24)
Age (mean 6 SD) 31.3 6 12.1 36.6 6 14.8
Sex (M/F) 5/19 6/18
Site of infection
Upper lip 12 13
Lower lip 5 2
Both 7 9
consent. Current antiviral or immunosuppressive therapy, homeopathy or
acupuncture as well as HIV infection were exclusion criteria. Patients’
characteristics are given in Table I.
Intervention All patients in both groups were treated by the same
physician in the recurrence-free period. Patients in the laser group received
low-intensity laser therapy by means of an 80 mW, 690 nm continuous
wave diode laser (Helbo Lasers, Gallspach, Austria). Irradiations (exposure
time, 10 min; area, 1 cm2; intensity, 80 mW per cm2; dose, 48 J per cm2)
once daily for 2 wk at the site of original chronic herpes infection. In
those patients with herpes infections located on both the upper and lower
lip both sites were irradiated. The placebo irradiation was performed in
the same manner as in the verum group except that the laser was not
turned on. Patients in both groups were wearing nontransparent protection
glasses during the procedure. Any pre-existing medication was left
unchanged during the trial. After completing the irradiation procedure
patients were told to present at the department at the time of recurrence.
The total observation period was 52 wk. The evaluator was not aware of
the study protocol.
Statistical analysis The median periods of remission intervals of the
laser-treated group and the placebo group were compared using Wilcoxon’s
Rank Sum Test. p , 0.05 were regarded as statistically significant.
RESULTS
Two of 50 enrolled subjects did not complete the study: one
patient of the placebo group discontinued because of time problems
and one patient of the laser group had to undergo an appendectomy.
All remaining 48 patients were monitored for 52 wk. One of these
patients was still in remission at the end of the observation period
but was not followed up. No side-effects of any kind were noted.
The treatment outcome is shown in Fig 1. The median
recurrence-free interval in the laser-treated group was 37.5 wk
(range, 2–52 wk; 95% confidence interval, 24–42 wk) compared
with 3 wk (range, 1–20 wk; 95% confidence interval, 2–4 wk) in
the placebo group. This difference was found to be statistically
significant (p , 0.0001). No influence of the anatomic site of
infection on the treatment outcome could be documented.
DISCUSSION
In this study we demonstrated the efficacy of low-intensity laser
therapy in the treatment of recurrent herpes simplex infection in a
randomized, double-blind placebo-controlled trial design. These
results confirm earlier findings from retrospective, uncontrolled
studies (Haichenberger-Wildner and Michels, 1981; Landthaler
et al, 1983).
Although potent agents against herpesvirus infections have
become available during the last decade, the increasing clinical use
of acyclovir and famciclovir has been associated with the emergence
of drug-resistant herpesvirus strains (Reusser, 1996). Moreover, the
intermittent administration of acyclovir does not alter the frequency
of recurrences (Whitley and Kimberlin, 1998). Owing to these
facts and because of the increasing patient demand for nonchemical
therapies various alternative treatment modalities have been intro-
duced, among which the combination of neutral red with laser
exposure as a photodynamic treatment modality deserves to be
mentioned from the photobiologic viewpoint (Felber et al, 1973).
Whereas ultraviolet radiation, in general, alters various cutaneous
Figure 1. Low intensity laser therapy lowers the incidence of local
recurrence of perioral herpes simplex infection. Remission intervals
after 10 sessions of 690 nm low-intensity laser therapy (median 37.5 wk,
range 2.0–, 52 wk) and placebo treatment (median 3.0 wk, range 1.0–
20.0 wk) in patients with recurrent perioral herpes simplex infection.
The difference between the groups (n 5 24) was statistically significant
(p , 0.0001, Wilcoxon’s Rank Sum Test). Bars indicate the respective
medians and 95% confidence intervals. Arrow indicates censored value
(patient with remission interval longer than 52 wk).
cell functions, little is known about immune-modulating effects of
(low-intensity) red and near infrared light on the skin. Low-
intensity laser therapy has been introduced mainly for the induction
of wound healing and pain therapy in the 1970s (Mester et al,
1971). Since then, a number of reports investigated a putative
influence of this athermic phototherapy on the immune system
and its constituents (Ohta et al, 1987; Yu et al, 1997b; Schindl et al,
1997c). These experiments, however, yielded conflicting results
which can be explained in part by the different irradiation parameters
used and the well-established fluence-dependence of (laser) light
effects (Inoue et al, 1989a; Funk et al, 1992).
Danno and Sugie (1996) demonstrated that a weak thermal effect
induced by near infrared exposure reversibly suppressed the density
of Langerhans cells and the ability of the skin to induce contact
hypersensitivity reactions. Inoue et al (1989b) described suppressed
tuberculin reactions in guinea pigs and a possible systemic inhibitory
effect on delayed hypersensitivity reactions after a single low power
laser irradiation at a fluence of 3.6 J per cm2. In contrast to
ultraviolet radiation which is known to have an inductive effect
on herpes simplex infection (Norval and el Ghorr, 1996), the results
of this study, together with findings from other authors dealing
with the effect of low-intensity laser therapy for the treatment of
herpes simplex (Ko¨rner et al, 1989; Perrin et al, 1997) and herpes
zoster (Moore et al, 1988; Moore and Calderhead, 1991; Matsumura
et al, 1993) show an immune-stimulating effect. Ko¨rner et al (1989)
used a Nd:YAG laser operated at fluences between 5 and 183 J per
cm2 and found no direct virus-inactivating effect on HSV-1 cultures
but a 50% reduction in virus yield in cultures incubated with
irradiated leukocytes. This observation could provide a possible
explanation of the mechanism of the treatment effect and is backed
by results from other investigators reporting on the activation and
proliferation of lymphocytes (Inoue et al, 1989a; Yu et al, 1997b;
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Schindl et al, 1997c; Manteifel et al, 1997) and macrophages (Bolton
et al, 1990) as well as the synthesis and expression of cytokines
(Funk et al, 1992; Yu et al, 1996) following low intensities of red
and near-infrared laser light. Utilizing a krypton-laser (wavelength
647 nm) at similar irradiation parameters as applied in our study
(intensity, 50 mW per cm2; fluence, 4.5 J per cm2), Landthaler
et al (1983) achieved a significant prolongation of remission intervals
from 30 to 73 d in patients with recurrent herpes simplex infection.
Interestingly, patients with labial herpes infection showed better
results than those with genital infection.
A psychologic influence on herpes infection is well established
(Luby and Klinge, 1985; Biondi and Zannino, 1997) and also has
been described for low-intensity laser therapy (Zimmermann,
1990). Such an influence could clearly be ruled out in our study
due to the selected randomized, double-blind placebo-controlled
trial design.
In conclusion, we demonstrated that a total of 10 daily irradiations
by means of a low-intensity laser device significantly lowers the
incidence of local recurrence of perioral herpes simplex infection.
This athermic phototherapeutic procedure represents a safe, rela-
tively cost-effective, and noninvasive treatment modality. There-
fore, it may be considered as a beneficial alternate treatment
regimen for recurring herpes simplex infections. Future work will
focus on the elucidation of the underlying mechanisms and the
potential role of this therapy. Additionally, larger studies are needed
to evaluate the influence of the type of HSV (HSV-1 versus HSV-
2) and different irradiation protocols on the effects of laser therapy
in recurrent perioral herpes simplex infection.
REFERENCES
Al-Watban FAH, Zhang XY: Comparison of the effects of laser therapy on wound
healing using different laser wavelengths. Laser Ther 8:127–135, 1996
Biondi M, Zannino LG: Psychological stress, neuroimmunomodulation, and
susceptibility to infectious diseases in animals and man: a review. Psychother
Psychosom 66:3–26, 1997
Bolton P, Young SR, Dyson M: Macrophage responsiveness to light therapy: a dose
response study. Laser Ther 2:101–106, 1990
Danno K, Sugie N: Effects of near-infrared radiation on the epidermal proliferation
and cutaneous immune function in mice. Photodermatol Photoimmunol Photomed
12:233–236, 1996
Emmanoulidis O, Diamantopoulos C: CW IR low-power laser application
significantly accelerates chronic pain relief rehabilitation of professional athletes.
A double blind study. Lasers Surg Med 6:173, 1986
Felber TD, Smith EB, Knox JM, Wallis G, Melnick JL: Photodynamic inactivation
of herpes simplex. JAMA 223:289–292, 1973
Funk JO, Kruse A, Kirchner H: Cytokine production after helium-neon laser
irradiation in cultures of human peripheral blood mononuclear cells. J Photochem
Photobiol B 16:347–355, 1992
Haichenberger-Wildner I, Michels H: Laserstrahlen bei Herpeserkrankungen. Med
Cosmetol 11:142–144, 1981
Halevy S, Lubart R, Reuveni H, Grossman N: 780nm low power laser therapy for
wound healing-in vivo and in vitro studies. Laser Ther 9:159–164, 1997
Inoue K, Nishioka J, Hukuda S: Altered lymphocyte proliferation by low dosage
laser irradiation. Clin Exp Rheumatol 7:521–523, 1989a
Inoue K, Nishioka J, Hukuda S: Suppressed tuberculin reaction in guinea pigs
following laser irradiation. Lasers Surg Med 9:271–275, 1989b
Ko¨rner R, Bahmer F, Wigand R: The effect of infrared laser rays on herpes simplex
virus and the functions of immunocompetent cells. Hautarzt 40:350–354, 1989
Landthaler M, Haina D, Waidelich W: Behandlung von Zoster, postzosterischen
Schmerzen und Herpes simplex recidivans in loco mit Laser-Licht. Fortschritte
Med 101:1039–1041, 1983
Luby ED, Klinge V: Genital herpes. A pervasive psychosocial disorder. Arch Dermatol
121:494–497, 1985
Manteifel V, Bakeevo L, Kern T: Define structural changes in chondriome of
human lymphocytes after irradiation with He–Ne laser: appearance of giant
mitochondria. J Photochem Photobiol B: Biol 38:25–30, 1997
Matsumura C, Ishikawa F, Imai M, Kemmotsu O: Useful effect of application of
helium-neon LLLT on an early stage case of herpes zoster: a case report. Laser
Ther 5:43–46, 1993
Mester E, Spiry T, Szende B, Tota JG: Effect of laser rays on wound healing. Am J
Surg 122:532–535, 1971
Moore KC, Calderhead RG: The clinical application of low incident power density
830nm GaAlAs diode laser radiation in the therapy of chronic intractable pain:
a historical and optoelectronical rationale and clinical review. Int J Optoelectronics
6:503–520, 1991
Moore KC, Hira N, Kumar PS, Jayakumar CS, Oshiro T: A double blind crossover
trial of low level laser therapy in the treatment of post herpetic neuralgia. Laser
Ther 1:7–9, 1988
Norval M, el Ghorr AA: UV radiation and mouse models of herpes simplex virus
infection. Photochem Photobiol 64:242–245, 1996
Ohta A, Abergel RP, Uitto J: Laser modulation of human immune system: inhibition
of lymphocyte proliferation by a gallium-arsenide laser at low energy. Lasers
Surg Med 7:199–201, 1987
Perrin D, Jolivald JR, Triki H, et al: Effect of laser irradiation on latency of herpes
simplex virus in a mouse model. Pathol Biol Paris 45:24–27, 1997
Reusser P: Herpesvirus resistance to antiviral drugs: a review of the mechanisms,
clinical importance and therapeutic options. J Hosp Infect 33:235–248, 1996
Schindl A, Schindl M, Schindl L: Successful phototherapy with low intensity laser
irradiation of a chronic radiation ulcer in a patient with lupus erythematosus
and diabetes mellitus. Br J Dermatol 137:840–841, 1997a
Schindl A, Schindl M, Schindl L: Successful treatment of persistent radiation ulcer
by low power laser therapy. J Am Acad Dermatol 37:646–648, 1997b
Schindl L, Schindl M, Polo L, Jori G, Perl S, Schindl A: Effects of low power laser-
irradiation on differential blood count and body temperature in endotoxin-
preimmunized rabbits. Life Sci 60:1669–1677, 1997c
Vestey JP, Norval M: Mucocutaneous infections with herpes simplex virus and their
management. Clin Exp Dermatol 17:221–234, 1992
Walker JB: Relief from chronic pain by low power laser irradiation. Neurosci Lett
43:339–344, 1983
Whitley RJ, Kimberlin DW: Herpes simplex viruses. Clin Infect Dis 26:541–555, 1998
Yu H, Chang K, Yu C, Chen J, Chen G: Low-energy helium neon laser irradiation
stimulates IL-1 and IL-8 release from cultured human keratinocytes. J Invest
Dermatol 107:593–596, 1996
Yu W, Naim JO, Lanzafame RJ: Effects of photostimulation on wound healing in
diabetic mice. Lasers Surg Med 20:56–63, 1997a
Yu W, Chi L, Naim JO, Lanzafame RJ: Improvement of host response to sepsis by
photobiomodulation. Lasers Surg Med 21:262–268, 1997b
Zimmermann M: Studies on the therapeutic efficacy of a HeNe laser. Dtsch Z Mund
Kieferheilkd Gesichtschir 14:313–319, 1990
